|
Originally published In Press as doi:10.1074/jbc.M300749200 on February 11, 2003
J. Biol. Chem., Vol. 278, Issue 16, 13975-13983, April 18, 2003
The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome
Proliferator-activated Receptor and Target Gene*
Olivier
Barbier ,
Lyne
Villeneuve§,
Virginie
Bocher ,
Coralie
Fontaine ,
Ines
Pineda
Torra ,
Christian
Duhem ,
Vladimir
Kosykh¶,
Jean-Charles
Fruchart ,
Chantal
Guillemette§, and
Bart
Staels
From the UR 545 INSERM, Département
d'Athérosclérose, Institut Pasteur de Lille and the
Faculté de Pharmacie, Université de Lille II, Lille 59019, France, the § Oncology and Molecular Endocrinology Research
Center, CHUL Research Center and Faculty of Pharmacy, Laval University,
Quebec G1V 4G2, Canada, and ¶ Institute of Experimental
Cardiology, Russian Cardiology Complex, Moscow 121552, Russia
Peroxisome proliferator-activated
receptor (PPAR) and are ligand-activated transcription factors
belonging to the nuclear receptor family. PPAR mediates the
hypolipidemic action of the fibrates, whereas PPAR is a receptor for
the antidiabetic glitazones. In the present study, the
UDP-glucuronosyltransferase (UGT) 1A9 enzyme is identified as a PPAR
and PPAR target gene. UGTs catalyze the glucuronidation reaction,
which is a major pathway in the catabolism and elimination of numerous
endo- and xenobiotics. Among the UGT1A family enzymes, UGT1A9
metabolizes endogenous compounds, including catecholestrogens, and
xenobiotics, such as fibrates and to a lesser extent troglitazone.
Treatment of human hepatocytes and macrophages and murine adipocytes
with activators of PPAR or PPAR resulted in an enhanced UGT1A9
expression and activity. In addition, disruption of the PPAR gene in
mice completely abolished the PPAR agonist-induced UGT1A9 mRNA
and activity levels. A PPAR response element was identified in the
promoter of UGT1A9 at positions 719 to 706 bp by transient
transfection and electromobility shift assays. Considering the role of
UGT1A9 in catecholestrogen metabolism, PPAR and PPAR activation
may contribute to the protection against genotoxic catecholestrogens by
stimulating their inactivation in glucuronide derivatives. Furthermore,
since UGT1A9 is involved in the catabolism of fibrates, these results
suggest that PPAR and PPAR may control the intracellular level of
active fibrates.
*
This work was supported by grants from the Fondation
Lefoulon-Delalande, Institut de France (to O. B.), European
Community Grant ERBFMBICT983214 (to I. P. T.), Fonds Européens
de Developpement Régional, Conseil Régional
Région Nord/Pas-de-Calais Genopole Project 01360124, grants from
the Leducq Foundation (to B. S. and J. C. F.), Canadian Institutes
of Health Research Grants MOP-44032 and MSH-46809, and Fonds de la
Recherche en Santé du Québec Grant 13408-166 (to C. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom all correspondence should be addressed: Unité
INSERM 545, Institut Pasteur de Lille, 1 rue du Pr. Calmette, BP 245, 59019 Lille, France. Tel.: 33-3-20-87-73-87; Fax: 33-3-20-87-71-98; E-mail: bart.staels@pasteur-lille.fr.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. B. Buckley and C. D. Klaassen
Induction of Mouse UDP-Glucuronosyltransferase mRNA Expression in Liver and Intestine by Activators of Aryl-Hydrocarbon Receptor, Constitutive Androstane Receptor, Pregnane X Receptor, Peroxisome Proliferator-Activated Receptor {alpha}, and Nuclear Factor Erythroid 2-Related Factor 2
Drug Metab. Dispos.,
April 1, 2009;
37(4):
847 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Emi, S.-i. Ikushiro, and Y. Kato
Thyroxine-Metabolizing Rat Uridine Diphosphate-Glucuronosyltransferase 1A7 Is Regulated by Thyroid Hormone Receptor
Endocrinology,
December 1, 2007;
148(12):
6124 - 6133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhen, K. W. Krausz, C. Chen, J. R. Idle, and F. J. Gonzalez
Metabolomic and Genetic Analysis of Biomarkers for Peroxisome Proliferator-Activated Receptor {alpha} Expression and Activation
Mol. Endocrinol.,
September 1, 2007;
21(9):
2136 - 2151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ashibe, T. Hirai, K. Higashi, K. Sekimizu, and K. Motojima
Dual Subcellular Localization in the Endoplasmic Reticulum and Peroxisomes and a Vital Role in Protecting against Oxidative Stress of Fatty Aldehyde Dehydrogenase Are Achieved by Alternative Splicing
J. Biol. Chem.,
July 13, 2007;
282(28):
20763 - 20773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-F. Yueh and R. H. Tukey
Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice
J. Biol. Chem.,
March 23, 2007;
282(12):
8749 - 8758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Senekeo-Effenberger, S. Chen, E. Brace-Sinnokrak, J. A. Bonzo, M.-F. Yueh, U. Argikar, J. Kaeding, J. Trottier, R. P. Remmel, J. K. Ritter, et al.
Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor {alpha} Activation
Drug Metab. Dispos.,
March 1, 2007;
35(3):
419 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Luci, H. Kluge, F. Hirche, and K. Eder
Clofibrate Increases Hepatic Triiodothyronine (T3)- and Thyroxine (T4)-Glucuronosyltransferase Activities and Lowers Plasma T3 and T4 Concentrations in Pigs
Drug Metab. Dispos.,
November 1, 2006;
34(11):
1887 - 1892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Shelby and C. D. Klaassen
Induction of Rat UDP-Glucuronosyltransferases in Liver and Duodenum by Microsomal Enzyme Inducers That Activate Various Transcriptional Pathways
Drug Metab. Dispos.,
October 1, 2006;
34(10):
1772 - 1778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Szatmari, G. Vamosi, P. Brazda, B. L. Balint, S. Benko, L. Szeles, V. Jeney, C. Ozvegy-Laczka, A. Szanto, E. Barta, et al.
Peroxisome Proliferator-activated Receptor {gamma}-regulated ABCG2 Expression Confers Cytoprotection to Human Dendritic Cells
J. Biol. Chem.,
August 18, 2006;
281(33):
23812 - 23823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, D. Beaton, N. Nguyen, K. Senekeo-Effenberger, E. Brace-Sinnokrak, U. Argikar, R. P. Remmel, J. Trottier, O. Barbier, J. K. Ritter, et al.
Tissue-specific, Inducible, and Hormonal Control of the Human UDP-Glucuronosyltransferase-1 (UGT1) Locus
J. Biol. Chem.,
November 11, 2005;
280(45):
37547 - 37557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Barbier, H. Girard, Y. Inoue, H. Duez, L. Villeneuve, A. Kamiya, J.-C. Fruchart, C. Guillemette, F. J. Gonzalez, and B. Staels
Hepatic Expression of the UGT1A9 Gene Is Governed by Hepatocyte Nuclear Factor 4{alpha}
Mol. Pharmacol.,
January 1, 2005;
67(1):
241 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Williams, R. Hyland, B. C. Jones, D. A. Smith, S. Hurst, T. C. Goosen, V. Peterkin, J. R. Koup, and S. E. Ball
DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
Drug Metab. Dispos.,
November 1, 2004;
32(11):
1201 - 1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Soars, D. M. Petullo, J. A. Eckstein, S. C. Kasper, and S. A. Wrighton
AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
Drug Metab. Dispos.,
January 1, 2004;
32(1):
140 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Gregory, D. A. Gardner-Stephen, R. H. Lewinsky, K. N. Duncliffe, and P. I. Mackenzie
Cloning and Characterization of the Human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 Gene Promoters: DIFFERENTIAL REGULATION THROUGH AN INITIATOR-LIKE REGION
J. Biol. Chem.,
September 19, 2003;
278(38):
36107 - 36114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Barbier, D. Duran-Sandoval, I. Pineda-Torra, V. Kosykh, J.-C. Fruchart, and B. Staels
Peroxisome Proliferator-activated Receptor {alpha} Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme
J. Biol. Chem.,
August 29, 2003;
278(35):
32852 - 32860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jinno, M. Saeki, Y. Saito, T. Tanaka-Kagawa, N. Hanioka, K. Sai, N. Kaniwa, M. Ando, K. Shirao, H. Minami, et al.
Functional Characterization of Human UDP-Glucuronosyltransferase 1A9 Variant, D256N, Found in Japanese Cancer Patients
J. Pharmacol. Exp. Ther.,
August 1, 2003;
306(2):
688 - 693.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|